Security key
10919W405
BRIGHT MINDS BIOSCIENCES INC. - COMMON STOCK, WITHOUT PAR VALUE (DRUG)
CUSIP: 10919W405
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / COMMON STOCK, WITHOUT PAR VALUE
- Total 13F shares
- 5,217,399
- Total 13F value
- $188,361,504
- Share change
- +319,267
- SEC-reported price per share
- $36.07
- Number of holders
- 34
- Value change
- +$11,625,261
- Number of buys
- 19
- Number of sells
- 15
- Shares outstanding
- 10,194,635
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
34
Top holders
10
DRUG full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
BRIGHT MINDS BIOSCIENCES INC. SEC filings
BRIGHT MINDS BIOSCIENCES INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 10919W405
Recent filing periods:
Ownership snapshot
Top reported holders of DRUG - BRIGHT MINDS BIOSCIENCES INC. - COMMON STOCK, WITHOUT PAR VALUE (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ian McDonald
Disclosed value leader
Ian McDonald
Comparable rows
15/15
Latest evidence
31 Dec 2024
13D/G
13F
Lead comparable stake: 14%
13D/G row: Ian McDonald
Showing 1-6 of 15 holder rows.
Quick read
Ian McDonald leads the comparable SEC ownership view at 14%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ian McDonald's linked filing trail.
Comparable ownership
Top 5
Ian McDonald
14%
Point72 Asset Management, L.P.
3%
RA CAPITAL MANAGEMENT, L.P.
2.9%
Cormorant Asset Management, LP
10%
Janus Henderson Group Ltd.
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ian McDonald |
13D/G
|
14%
|
$85,992,664
1,396,665 shares
|
$0 | 04 Nov 2024 |
| Point72 Asset Management, L.P. |
13F
13D/G
Company
|
3%
from 13D/G
|
$4,869,508
135,189 shares
|
— | 31 Dec 2024 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
13D/G
Company
|
2.9%
from 13D/G
|
$16,599,061
460,829 shares
|
— | 31 Dec 2024 |
| Cormorant Asset Management, LP |
13F
Company
|
10%
|
$38,157,103
1,059,331 shares
|
— | 31 Dec 2024 |
| Janus Henderson Group Ltd. |
13F
Company
|
5%
|
$18,392,252
508,776 shares
|
— | 31 Dec 2024 |
| Commodore Capital LP |
13F
Company
|
4.9%
|
$18,010,000
500,000 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
34
Shares
5,217,399
Rows available
34
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2026 Across Filers
Q1 2026 holders
94
Q1 2025 holders
34
Holder diff
-60
| Investor | Q1 2026 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend